文献速递腹部技术与安全CT

对比增强CT衍生的细胞外容积分数预测术后胰腺癌患者生存

Contrast-enhanced CT-Derived extracellular volume fraction predicts survival in postoperative pancreatic cancer patients.
PubMed 文献 · Eur J Radiol · 2025-06-27

本研究纳入166例2018年1月至2021年3月间术前接受对比增强CT的可切除胰腺导管腺癌患者,计算肿瘤CT衍生细胞外容积分数(中位值32%,范围21%-41%)。多因素分析显示年龄和ECV分数是总生存的独立预测因子(p=0.012;p=0.001),肿瘤大小和ECV分数是无进展生存的独立预测因子(p=0.016;p=0.001)。ECV与胶原比例强相关(R2=0.860,p<0.001)。

要点

  • 肿瘤CT衍生ECV分数中位值为32%(范围21%-41%),可作为可切除PDAC术后生存的非侵入性生物标志物。
  • ECV分数是总生存(p=0.001)和无进展生存(p=0.001)的独立预测因子。
  • ECV与手术标本Masson三色染色胶原比例强相关(R2=0.860,p<0.001)。

核心结论

  • CT衍生ECV分数是可切除胰腺导管腺癌术后生存的非侵入性预测生物标志物。

研究设计与样本

  • 研究纳入166例可切除PDAC患者,于2018年1月至2021年3月术前接受对比增强CT,从平扫和平衡期CT图像计算肿瘤ECV分数,采用Cox比例风险模型进行单因素和多因素分析,并对部分手术切除标本行Masson三色染色量化肿瘤内胶原含量。

关键影像表现/征象

  • 肿瘤CT衍生ECV分数中位值为32%(范围21%-41%)。
  • 肿瘤CT衍生ECV分数升高与总生存和无进展生存的正面效应相关。
  • ECV与胶原比例强相关(R2=0.860,p<0.001)。

诊断标准与关键数值

  • ECV分数是术后PDAC患者总生存的独立预测因子(p=0.001)。
  • ECV分数是术后PDAC患者无进展生存的独立预测因子(p=0.001)。
  • 年龄是总生存的独立预测因子(p=0.012),肿瘤大小是无进展生存的独立预测因子(p=0.016)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate the prognostic value of extracellular volume (ECV) fraction derived from contrast-enhanced computed tomography (CECT) in predicting survival outcomes of resectable pancreatic ductal adenocarcinoma (PDAC).

METHODS: The study cohort included a total of 166 patients with resectable PDAC who underwent CECT before operative excision between Jan 2018 and Mar 2021. Tumor CT-derived ECV fractions were calculated from unenhanced and equilibrium-phase CT images. The effects of clinical factors, CECT parameters, and tumor CT-derived ECV fractions on overall survival (OS) and progression-free survival (PFS) were assessed by univariate and multivariate analyses using Cox proportional hazards models. In order to verify the reliability of ECV, Masson's Trichrome staining was performed on surgical resection specimens from a subset of patients to quantify intratumoral collagen content. Pearson correlation analyzed relationships between CT-derived ECV and collagen ratio (CR).

RESULTS: The median value of CT-derived ECV fraction was 32 % (21 % - 41 %) . Increasing tumor CT-derived ECV fractions were associated with a positive effect on OS and PFS. Age and CT-derived ECV fraction was an independent predictor of OS (p = 0.012; p = 0.001) in patients with postoperative PDAC. Tumor size and CT-derived ECV fraction was an independent predictor of PFS (p = 0.016; p = 0.001) in patients with postoperative PDAC. ECV strongly correlated with CR (R2 = 0.860, p < 0.001).

CONCLUSION: CT-derived ECV fraction is a noninvasive biomarker for predicting survival in resectable PDAC.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Ming S, Zhang W, Wang M, et al. Contrast-enhanced CT-Derived extracellular volume fraction predicts survival in postoperative pancreatic cancer patients. Eur J Radiol. 2025. PMID: 40618544. doi:10.1016/j.ejrad.2025.112273

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。